BRAZE INC-A (BRZE) Stock Fundamental Analysis
USA - NASDAQ:BRZE - US10576N1028 - Common Stock
27 USD
-0.22 (-0.81%)
26.8269 USD
-0.17 (-0.64%)
Taking everything into account, BRZE scores 4 out of 10 in our fundamental rating. BRZE was compared to 281 industry peers in the Software industry. While BRZE seems to be doing ok healthwise, there are quite some concerns on its profitability. BRZE is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
BRZE had positive earnings in the past year.
BRZE had a positive operating cash flow in the past year.
In the past 5 years BRZE always reported negative net income.
In multiple years BRZE reported negative operating cash flow during the last 5 years.
1.2 Ratios
BRZE has a Return On Assets of -10.64%. This is in the lower half of the industry: BRZE underperforms 63.35% of its industry peers.
The Return On Equity of BRZE (-18.17%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.64% | ||
| ROE | -18.17% | ||
| ROIC | N/A |
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 68.79%, BRZE perfoms like the industry average, outperforming 50.89% of the companies in the same industry.
BRZE's Gross Margin has improved in the last couple of years.
BRZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BRZE has more shares outstanding
The number of shares outstanding for BRZE has been increased compared to 5 years ago.
There is no outstanding debt for BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
BRZE has an Altman-Z score of 3.77. This indicates that BRZE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.77, BRZE is in the better half of the industry, outperforming 67.26% of the companies in the same industry.
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.77 |
ROIC/WACCN/A
WACC11.05%
2.3 Liquidity
BRZE has a Current Ratio of 1.37. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.37, BRZE is in line with its industry, outperforming 43.06% of the companies in the same industry.
BRZE has a Quick Ratio of 1.37. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BRZE (1.37) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
BRZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 820.00%, which is quite impressive.
Looking at the last year, BRZE shows a very strong growth in Revenue. The Revenue has grown by 22.16%.
The Revenue has been growing by 43.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)22.16%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%23.79%
3.2 Future
BRZE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 56.56% yearly.
Based on estimates for the next years, BRZE will show a quite strong growth in Revenue. The Revenue will grow by 17.76% on average per year.
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y72.42%
EPS Next 5Y56.56%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.73%
Revenue Next 5Y17.76%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 75.00, which means the current valuation is very expensive for BRZE.
Compared to the rest of the industry, the Price/Earnings ratio of BRZE is on the same level as its industry peers.
BRZE is valuated expensively when we compare the Price/Earnings ratio to 25.07, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 51.57 indicates a quite expensive valuation of BRZE.
BRZE's Price/Forward Earnings ratio is in line with the industry average.
BRZE is valuated expensively when we compare the Price/Forward Earnings ratio to 34.08, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75 | ||
| Fwd PE | 51.57 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as BRZE.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 109.8 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BRZE's earnings are expected to grow with 72.42% in the coming years.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y70.55%
EPS Next 3Y72.42%
5. Dividend
5.1 Amount
No dividends for BRZE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
27
-0.22 (-0.81%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners72.77%
Inst Owner Change6.19%
Ins Owners5.64%
Ins Owner Change5.58%
Market Cap3.00B
Revenue(TTM)654.62M
Net Income(TTM)-108.79M
Analysts84.62
Price Target45.73 (69.37%)
Short Float %7%
Short Ratio3.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)220.59%
Min EPS beat(2)50.17%
Max EPS beat(2)391.01%
EPS beat(4)4
Avg EPS beat(4)272.62%
Min EPS beat(4)50.17%
Max EPS beat(4)523.5%
EPS beat(8)8
Avg EPS beat(8)199.67%
EPS beat(12)12
Avg EPS beat(12)146.67%
EPS beat(16)16
Avg EPS beat(16)117.22%
Revenue beat(2)2
Avg Revenue beat(2)1.97%
Min Revenue beat(2)0.14%
Max Revenue beat(2)3.8%
Revenue beat(4)4
Avg Revenue beat(4)1.38%
Min Revenue beat(4)0.14%
Max Revenue beat(4)3.8%
Revenue beat(8)8
Avg Revenue beat(8)1.72%
Revenue beat(12)12
Avg Revenue beat(12)1.7%
Revenue beat(16)16
Avg Revenue beat(16)2.89%
PT rev (1m)-0.63%
PT rev (3m)-0.37%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)194.56%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)137.69%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)2.23%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)2.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75 | ||
| Fwd PE | 51.57 | ||
| P/S | 4.59 | ||
| P/FCF | 109.8 | ||
| P/OCF | 81.71 | ||
| P/B | 5.02 | ||
| P/tB | 11.4 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.36
EY1.33%
EPS(NY)0.52
Fwd EY1.94%
FCF(TTM)0.25
FCFY0.91%
OCF(TTM)0.33
OCFY1.22%
SpS5.88
BVpS5.38
TBVpS2.37
PEG (NY)0.56
PEG (5Y)N/A
Graham Number6.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.64% | ||
| ROE | -18.17% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.79% | ||
| FCFM | 4.18% |
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 73.75% | ||
| Cap/Sales | 1.44% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 3.77 |
F-Score5
WACC11.05%
ROIC/WACCN/A
Cap/Depr(3y)240.58%
Cap/Depr(5y)230.69%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y72.42%
EPS Next 5Y56.56%
Revenue 1Y (TTM)22.16%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%23.79%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.73%
Revenue Next 5Y17.76%
EBIT growth 1Y10.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year761.05%
EBIT Next 3Y188.12%
EBIT Next 5Y120.97%
FCF growth 1Y201.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y294.75%
OCF growth 3YN/A
OCF growth 5YN/A
BRAZE INC-A / BRZE FAQ
Can you provide the ChartMill fundamental rating for BRAZE INC-A?
ChartMill assigns a fundamental rating of 4 / 10 to BRZE.
What is the valuation status of BRAZE INC-A (BRZE) stock?
ChartMill assigns a valuation rating of 3 / 10 to BRAZE INC-A (BRZE). This can be considered as Overvalued.
How profitable is BRAZE INC-A (BRZE) stock?
BRAZE INC-A (BRZE) has a profitability rating of 2 / 10.
Can you provide the PE and PB ratios for BRZE stock?
The Price/Earnings (PE) ratio for BRAZE INC-A (BRZE) is 75 and the Price/Book (PB) ratio is 5.02.
What is the earnings growth outlook for BRAZE INC-A?
The Earnings per Share (EPS) of BRAZE INC-A (BRZE) is expected to grow by 133.15% in the next year.